SCHEMBL7604058

SCHEMBL7604058

O=c1[nH]c(=O)n(-c2ccccc2)c2nc(Cc3ccccc3)[nH]c12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNP P00491 2/20 0.51
ADORA3 P0DMS8 1/20 0.47
KMT2A Q03164 2/20 0.47
TP53 P04637 1/20 0.46
GAA P10253 1/20 0.46
MAPT P10636 1/20 0.46
TSHR P16473 1/20 0.46
XBP1 P17861 1/20 0.46
MAPK1 P28482 1/20 0.46
ATM Q13315 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
PDE9A O76083 2/20 0.46
PDE1C Q14123 2/20 0.46
RNASEH1 O60930 1/20 0.43
DAO P14920 1/20 0.42
CSNK2A1 P68400 1/20 0.42
ADORA2A P29274 2/20 0.41
ADORA2B P29275 2/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7421517 0.91 PNP (0.46) PNPADORA3KMT2ATP53GAA
SCHEMBL7421927 0.89 CCNE2 (0.46) PNPADORA3KMT2ATP53GAA
SCHEMBL7422077 0.88 PNP (0.49) PNPADORA3KMT2ATP53GAA
SCHEMBL7416425 0.85 PNP (0.47) PNPKMT2ATP53GAAMAPT
SCHEMBL7420635 0.84 RIPK1 (0.48) PNPKMT2AGAAMAPTSMN1; SMN2
SCHEMBL3110928 0.78 PNP (0.48) PNPKMT2ATP53GAAMAPT
SCHEMBL3554510 0.77 CSNK2A1 (0.43) KMT2ATP53GAAMAPTTSHR
SCHEMBL3115741 0.77 ADORA2A (0.58) PNPKMT2AGAAATMSMN1; SMN2
SCHEMBL4013558 0.77 ADORA2A (0.42) PNPADORA3KMT2ATP53GAA
SCHEMBL19211636 0.76 CSNK2A1 (0.42) KMT2ATP53GAAMAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1257552-A1 XANTHINE DERIVATIVES, INTERMEDIATES AND USE FOR TREATING OSTEOPOROSIS Aventis Pharma S.A. (FR) 2002-11-20 EP disclosed
WO-2001060824-A1 XANTHINE DERIVATIVES, INTERMEDIATES AND USE FOR TREATING OSTEOPOROSIS AVENTIS PHARMA S.A. (FR) 2001-08-23 WO disclosed